[1] Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and the risk of coronary heart disease: 10, 158 incident cases among 262, 525 participants in 29 western prospective studies[J]. Circulation, 2007, 115(4): 45-48.[2] Gan S I, Edwards A L, Symonds C J, et al. Hypertriglyceridemia-induced pancreatitis: a case-based review[J]. World J Gastroenterol, 2006, 12(44): 7197-7202.[3] Prinsen B H, de Sain-vander Velden M G, de Koning E J, et al. Hypertriglyceridemia in patients with chronic renal failure: possible mechanisms[J]. Kidney Int Suppl, 2003, (84): S121-S124.[4] Xian X, Liu T, Yu J, et al. Presynaptic defects underlying impaired learning and memory function in lipoprotein lipase-deficient mice[J]. J Neurosci, 2009, 29(14): 4681-4685.[5] Ding Y L, Wang Y H, Huang W, et al. Glucose intolerance and decreased early insulin response in mice with severe hypertriglyceridemia[J]. Exp Biol Med, 2010, 235(1): 40-46.[6] Koukkou E, Watts G F, Lowy C. Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study[J]. J Clin Pathol, 1996, 49(8): 634-637.[7] Swisher S G, Hunt K K, Schmit P J, et al. Management of pancreatitis complicating pregnancy[J]. Am Surg, 1994, 60(10): 759-762.[8] Eddy J J, Gideonsen M D, Song J Y, et al. Pancreatitis in pregnancy[J]. Obstet Gynecol, 2008, 112(5): 1075-1081.[9] Reaven G M, Mondon C E, Chen Y D, et al. Hypertriglyceridemic mice transgenic for the human apolipoprotein C-Ⅲ gene are neither insulin resistant nor hyperinsulinemic[J]. J Lipid Res, 1994, 35(5): 820-824.[10] Brown W V, Baginsky M L. Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein[J]. Biochem Biophys Res Commun, 1972, 46(2): 375-382.[11] Wang C S, McConathy W J, Kloer H U, et al. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-Ⅲ[J]. J Clin Invest, 1985, 75(2): 384-390.[12] Pollin T I, Damcott C M, Shen H, et al. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection[J]. Science, 2008, 322(5908): 1702-1705.[13] Stalenhoef A F, Demacker P N, Lutterman J A, et al. Plasma lipoproteins, apolipoproteins, and triglyceride metabolism in familial hypertriglyceridemia[J]. Arteriosclerosis, 1986, 6(4): 387-394.[14] Ito Y, Azrolan N, OConnell A, et al. Hypertriglyceridemia as a result of human apo CⅢ gene expression in transgenic mice[J]. Science, 1990, 249(4970): 790-793.[15] Howard B V, Mayer-Davis E J, Goff D, et al. Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study[J]. Metabolism, 1998, 47(10): 1174-1179.[16] Pollex R L, Hegele R A. Genetic determinants of the metabolic syndrome[J]. Nat Clin Pract Cardiovasc Med, 2006, 3(9): 482-489.[17] Reaven G M, Mondon C E, Chen Y D, et al. Hypertriglyceridemic mice transgenic for the human apolipoprotein C-Ⅲ gene are neither insulin resistant nor hyperinsulinemic[J]. J Lipid Res, 1994, 35(5): 820-824.[18] Goharkhay N, Tamayo E H, Yin H, et al. Maternal hypercholesterolemia leads to activation of endogenous cholesterol synthesis in the offspring[J]. Am J Obstet Gynecol, 2008, 199(3): 273.e1-6.[19] 崔常清.胰岛素抵抗的机制与临床研究进展[J].中国煤炭工业医学杂志, 2012, 15(7):1119-1121.[20] 胡丽叶, 朱旅云, 李晓玲, 等.不同糖耐量人群胰岛素抵抗指数及血管内皮功能变化的意义[J].临床误诊误治, 2010, 23(4):309-311. |